Business Context and Reporting Period
Company: Ironwood Pharmaceuticals, Inc. (IRWD)
Filing Type: Form 8-K (Current Report)
Date of Report: March 21, 2025 (Event Date); Signed March 27, 2025
Context: The Company reported receiving a notification from Nasdaq regarding a failure to comply with listing rules due to a delay in filing its Annual Report on Form 10-K for the year ended December 31, 2024.
Key Financial Metrics
This filing is a current report regarding regulatory compliance and does not contain financial performance data. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Events
- Nasdaq Non-Compliance Notice: On March 21, 2025, the Company received a notice from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of the 2024 Form 10-K.
- Immediate Effect: The notice has no immediate effect on the listing of the Company's securities on the Nasdaq Global Select Market.
- Compliance Timeline:
- Plan Submission Deadline: The Company has 60 calendar days (until May 20, 2025) to submit a plan to regain compliance.
- Extended Filing Deadline: If the plan is accepted, Nasdaq may grant up to 180 calendar days from the original due date (until September 1, 2025) to file the 2024 Form 10-K.
Guidance, Outlook, and Risks
Management Commentary: The Company plans to file its 2024 Form 10-K as soon as practicable and expects to regain compliance with Nasdaq rules.
Risks and Contingencies:
- The filing contains forward-looking statements regarding the expectation to regain compliance, which are subject to risks and uncertainties.
- Failure to submit a plan or file the 10-K within the granted timelines could result in delisting.
- Investors are referred to the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2023, for a discussion of important factors that could cause actual results to differ.
Investor Verification Checklist
- Verify the status of the 2024 Form 10-K filing on the SEC EDGAR database.
- Monitor for the submission of a compliance plan to Nasdaq by May 20, 2025.
- Review the press release dated March 27, 2025 (Exhibit 99.1) for additional details on the situation.
- Assess the potential impact of the filing delay on the Company's ability to access capital markets or maintain investor confidence.